<DOC>
	<DOCNO>NCT00480740</DOCNO>
	<brief_summary>The purpose study examine pharmacokinetics , pharmacodynamics , pharmacogenomics dexmedetomidine follow three pediatric patient population : patient bi-directional cavopulmonary anastomosis Fontan procedure , patient cardiac transplant , patient otherwise normal physiology undergoing closure patent ductus arteriosis atrial septal defect .</brief_summary>
	<brief_title>The Pharmacology Hemodynamics Dexmedetomidine Children With Congenital Heart Disease</brief_title>
	<detailed_description>While opioid analgesia currently mainstream management pain perioperative setting , often lead significant morbidity , include opioid tolerance hyperalgesia . Looking way decrease need opioids use adjunct medication allow long-term goal decrease physiologic tolerance child . This especially relevant pediatric congenital heart population . Dexmedetomidine class drug know alpha-2 agonist know provide analgesia , attenuate opioid tolerance inhibit sympathetic stress response . While numerous publish case study dexmedetomidine validate effectiveness safety , pharmacologic pharmacodynamic profile establish . This study examine hemodynamics , pharmacokinetics , pharmacogenomics dexmedetomidine patient congenital heart disease . The dose-ranging effect dexmedetomidine also investigate . The three group study : patient bi-directional cavopulmonary anastomosis Fontan procedure , patient cardiac transplant , patient otherwise normal physiology undergoing closure patent ductus arteriosis atrial septal defect . Comparison : Compare invasive noninvasive hemodynamic parameter baseline sevoflurane maintenance dose dexmedetomidine . The pharmacokinetics dexmedetomidine pediatric population follow escalate load dos continuous infusion time interval estimate . The efficacy dexmedetomidine estimate amount rescue dose propofol give .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects , Atrial</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>age birth 18 year &gt; = 6 kg . American Society Anesthesiology ( ASA ) I , II , III undergone prior cardiac transplant , Fontan patent ductus arterious atrial septal defect . schedule cardiac catheterization subject family history malignant hyperthermia know hepatic disorder determine history physical exam laboratory test pregnant lactate female receive inotropic agent pacemaker weigh less 6 kg .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Congenital heart disease</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>pediatric</keyword>
	<keyword>Bidirectional cavopulmonary anastomosis</keyword>
	<keyword>Fontan physiology</keyword>
	<keyword>Cardiac transplant</keyword>
</DOC>